Starland disposes its subsidiaries to GRP Limited

Consideration for the sale is around $36.6 m.

It is going to be give and take for Singapore-listed property developer Starland Holdings as it enters disposal of its subsidiaries to make way for a proposed acquisition.

Starland has entered a sale and purchase agreement with GRP Limited for the disposal of Starland Axis Pte. Ltd and Starland Commercial Trading Pte. Ltd.

According to the group, the maneuver is to make way for it acquisition of equity interest in Ayondo Holding AG.

"In addition, the existing business of the Company is divested so that the Company will have no operating business prior to the completion of the Proposed Acquisition and so that it will not affect the financial results of the Company after the Proposed Acquisition," the group explained in their announcement.

That sale consideration for the two subsidiaries was set to $36.6 million (RMB 179.4 million). The company expects to gain around $34.6 million (RMB 169.6 million) from the disposal.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare